References
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington DC: American Psychiatric Association; 1994
- Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289: 3095–105
- World Health Organization. The World Health Report 2002: reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization; 2002
- Hirschfeld RM, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 1997;277:333–40
- Leon AC, Solomon DA, Mueller TI, et al. A 20-year longitudinal observational study of somatic antidepressant treatment effectiveness. Am J Psychiatry 2003;160:727–33
- Meyers BS, Sirey JA, Bruce M, et al. Predictors of early recovery from major depression among persons admitted to community- based clinics: an observational study. Arch Gen Psychiatry 2002;59:729–35
- Lepola UM, Loft H, Reines EH. Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 2003;18: 211–7
- Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 2002;63:331–6
- Lexapro [package insert] St. Louis, MO: Forest Pharmaceuticals, Inc.; 2005
- Zoloft [package insert] New York, NY: Pfizer Inc.; 2006
- Fabre LF, Abuzzahab FS, Amin M, et al. Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Biol Psychiatry 1995;38:592–602
- IMS Health Incorporated Web site. Available from http://www.imshealth.com/ims/portal/pages/homeFlash/us/0,2764,6599,00.html [Last accessed 17 July 2006]
- Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 (Suppl 20):22–57
- Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–9
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62
- Guy W. ECDEU assessment manual for psychopharmacology. US Department Health, Education, and Welfare publication (ADM) 76–338. Rockville, MD: National Institute of Mental Health; 1976 pp.218–22
- Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50–5
- Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385–401
- Endicott J, Nee J, Harrison W, et al. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993;29:321–6